Farnesyltransferase inhibitors (FTIs) are currently under investigation for leukemia treatment. We evaluated the FTI manumycin A (manumycin) in two myeloid leukemia cell lines (U937 and HL-60). Manumycin induced nitric oxide production and apoptosis of the leukemia cells. Nitric oxide or other reactive oxygen species may induce oxidative DNA damage, and the number of apurinic sites increased after manumycin treatment, which was reversed by concurrent treatment with Nacetyl-L-cysteine. Since repair of DNA damage is important to cell survival, we hypothesized that methoxyamine, an inhibitor of base-excision repair, would enhance the antineoplastic effect of manumycin. The combination of manumycin and methoxyamine resulted in enhanced apoptosis by six criteriaincreased annexin V binding, release of mitochondrial cytochrome c into the cytosol, activation of caspase-9, activation of caspase-3, specific cleavage of poly-adenosyl ribose polymerase, and increase in the sub-G1 cell cycle fraction. The drug combination enhanced inhibition on the soft agar clonogenic assay and on the formazan dye cell viability assay. The effects of manumycin or manumycin plus methoxyamine on apoptosis were blocked by N-acetyl-L-cysteine, and partially by nitric oxide synthase inhibitors or scavenger of peroxide. We conclude that methoxyamine enhances manumycin-induced apoptosis in myeloid leukemia cells.
Introduction
Leukemia remains a deadly disease with 22 000 deaths in the United States in 2003. 1 Recent research has focused on targeted disruption of proliferation signal transduction and the utility of farnesyltransferase inhibitors (FTIs) in the treatment of leukemia. 2, 3 Recently, Selleri et al 4 demonstrated that FTIs increased NO to induce apoptosis in chronic myeloid leukemia cells, and this finding may potentially be exploited for rational design of combination chemotherapy.
Manumycin A (manumycin) is an FTI 5 that mimics the farnesyl pyrophosphate group. 6 Recently, we found that manumycin and other FTIs induced reactive oxygen species (ROS) (including superoxide and nitric oxide) and DNA damage in solid tumor cell lines (SC Jim Yeung, unpublished data).
Methoxyamine disrupts base-excision repair of DNA by reacting with the abasic sites and preventing endonuclease cleavage, 7 and DNA base-excision repair has been proposed as a potential therapeutic target to sensitize cancer cells to chemotherapy. 8 It has been reported that methoxyamine enhances the antineoplastic effect of alkylating agents and radiation. 8, 9 If base-excision repair plays a significant role in the repair of ROS-induced DNA damage and cell survival, then methoxyamine would enhance apoptosis induced by manumycin. We hypothesized that methoxyamine would enhance manumycin-induced apoptosis in leukemia cells. In this paper, we report the results of our investigations in a promyelocytic leukemia cell line (HL-60) and a myeloid leukemia cell line (U937).
Materials and methods

Cell culture
Human leukemia cell lines HL-60 and U937 from American Type Culture Collection were maintained in suspension culture with RPMI 1640 medium supplemented with heat-treated fetal bovine serum (10%) at 371C in a water-saturated atmosphere with 5% CO 2 . All experiments were carried out in exponentially growing cultures.
Chemicals and reagents
Manumycin A, methoxyamine, N-acetyl-L-cysteine (NAC), human erythrocyte catalase, N w -nitro-L-arginine methyl ester hydrochloride (L-NAME), N G -monomethyl-L-arginine acetate (L-NMMA), propidium iodide, digitonin, and mouse anti-actin monoclonal antibody were purchased from Sigma Chemical Co. (St Louis, MO, USA). All tissue culture media were purchased from Life Technologies Inc. (Gaithersburg, MD, USA). Anti-COX4 was purchased from Molecular Probes (Eugene, OR, USA). Mouse anti-cytochrome c monoclonal antibody and caspase-3 antibodies were purchased from Santa Cruz Biotechnologies (Santa Cruz, CA, USA). Rabbit anti-human caspase-9 and mouse anti-human poly-(ADP-ribose)-polymerase (PARP) were purchased from PharMingen (San Diego, CA, USA). ApoAlert cell fractionation kits and ApoAlert Nitric Oxide/Annexin V Dual Sensor kits were purchased from BD Biosciences Clontech Laboratories Inc. (Palo Alto, CA, USA). Manumycin, being lipophilic, was first dissolved in dimethyl sulfoxide (DMSO) (tissue culture grade, Sigma). The stock solution was diluted in tissue culture medium at appropriate concentrations such that the final concentration of DMSO in culture medium would not exceed 0.1% (v/v).
Fluorescent flow cytometry assay
Flow cytometry assays were performed at our Flow Cytometry Core Facility. Phycoerythrin (PE)-conjugated annexin V (Clontech) was used to detect cells undergoing apoptosis. In brief, cells were collected by centrifugation (200 g for 5 min at 41C) after experimental treatments and resuspended in annexin V binding buffer with annexin V-PE for 15 min at room temperature. After dilution, the cells were analyzed by flow cytometry for PE fluorescence (excitation: 488 nm; emission: 578 nm). To measure changes in intracellular NO level, a proprietary membranepermeable NO sensor dye was used according to the manufacturer's instructions (Clontech). Briefly, cells were preincubated with the NO sensor dye for 30 min prior to experimental treatments in the continued presence of the dye. The cells were pelleted by centrifugation, rinsed, and analyzed by flow cytometry for green fluorescence (excitation: 488 nm; emission: 515 nm). For dual NO/annexin V simultaneous flow cytometry analysis, the ApoAlert Nitric Oxide/Annexin V Dual Sensor Kit was used (Clontech). For cellular DNA content analysis by flow cytometry, nuclear DNA was stained with propidium iodide. Experimentally treated cells were centrifuged, washed twice with prechilled PBS, and fixed with 70% ethanol overnight at 41C. Cell pellets were resuspended in 500 ml of PBS after being washed twice with icecold PBS. Then, 50 ml of RNase (10 mg/ml) and 25 ml of propidium iodide (1 mg/ml) were added to the cells for 30 min at room temperature, and then flow cytometry analysis was performed.
Apurinic site assay
The apurinic sites assay was performed according to the manufacturer's instructions (Dojindo Molecular Technologies Inc., Gaithersburg, MD, USA). Briefly, 10 ml of genomic DNA (100 mg/ml) purified from U937 and HL-60 cells treated with DMSO control, manumycin 2 mM, NAC 5 mM, or both drugs was incubated with 10 ml of Aldehyde Reactive Probe reagent (N 0 -aminoxymethylcarbonylhydrazino D-biotin; ARP) (Dojindo Molecular Technologies Inc.) for 1 h at 371C. ARP reaction mixture was transferred to a filtration tube, and the tube was spun to isolate the ARP-labeled DNA. ARP-labeled DNA was added to a 96-well plate, binding solution was added, and the plate was left overnight. The DNA was incubated with 150 ml horseradish peroxidase-avidin for 1 h at 371C after being washed with washing buffer. Substrate solution was added, and absorbance was read at 650 nm. The standard curve for apurinic sites was generated using ARP-labeled standard DNA solution (Dojindo Molecular Technologies). The detection limit of this assay is one apurinic site per 1 Â 10 5 bp of DNA as estimated by the manufacturer.
Cytotoxicity assays
Cell growth inhibition or the relative number of viable cells was determined using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium (MTT) assay as previously described.
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Soft agar clonogenic assay
Cells were grown in six-well plates overnight and then treated with manumycin, methoxyamine, or both for 48 h. After treatment, cells were suspended in an equal volume of culture medium. The soft agar clonogenic assay was performed as previously described. 10 
SDS-PAGE and immunoblotting
Total cell extracts were prepared by lysing cells in Laemmli's SDS buffer. The DNA in the lysate was sheared by sonication with eight 1-s bursts at medium power. The cytosolic proteins were extracted from the cells using a digitonin buffer as previously described. 11 SDS-PAGE and immunoblotting were performed using standard methods with minor modifications as previously described. 10 
Statistics
The statistical significance of differences between groups was assessed using one-way analysis of variance (ANOVA) with Tukey's test or Student's t-test. Differences with Po0.05 were considered significant. The cytotoxic interaction between manumycin and methoxyamine was also assessed using the medianeffect method of Chou and Talalay. 12 The method has been described in detail elsewhere. Briefly, dose-response curves were obtained for manumycin and methoxyamine and for multiple dilutions of a fixed-ratio combination of the two drugs. The combination index (CI) was defined as the ratio of the combination dose to the sum of the single-agent doses at an isoeffective level. Therefore, CI values less than 1 indicate synergy, CI values greater than 1 indicate antagonism, and CI values equal to 1 indicate additivity. Calculations were performed using a computer program: CalcuSyn from BioSoft (Furguson, MO, USA).
Results
Manumycin-induced apoptosis and nitric oxide generation in leukemia cells
U937 and HL-60 cells were incubated with manumycin 2 mM for 6 h, and apoptosis was detected by annexin V-PE. Manumycin significantly (Po0.05, ANOVA, post hoc Tukey's test) increased the mean annexin V-PE binding to both cell lines compared with binding in the corresponding DMSO sham-treated control ( Figure 1a) . In another leukemia cell line, NO generation has been associated with FTI-induced apoptosis. 4 In U937 and HL-60 cells, manumycin also induced NO generation as demonstrated by the significant increase (Po0.05, ANOVA, post hoc Tukey's test) in the mean fluorescence of NO sensor dye in manumycin-treated cells compared with DMSO shamtreated control cells (Figure 1b) .
At 5 mM, NAC (a quencher of ROS) did not induce apoptosis and slightly increased (though not statistically significantly) NO generation in U937 and HL-60 cells ( Figure 1 ). When combined with manumycin, NAC completely blocked apoptosis induced by manumycin ( Figure 1a ) and blocked 480% of the increase in NO generation induced by manumycin in both cell lines (Figure 1b ). These findings suggested that ROS (including NO) generation was required for manumycin-induced apoptosis in U937 and HL-60 cells.
Manumycin increased the number of abasic sites in DNA
Since ROS could damage cellular DNA, we investigated whether manumycin could induce oxidative damage to DNA in U937 and HL-60 cells. Abasic or apurinic sites on DNA are generated in the process of base-excision repair. To test whether Enhancement of manumycin A-induced apoptosis by methoxyamine M She et al manumycin generated apurinic sites, we used ARP to measure apurinic sites formed in cellular DNA after manumycin treatment. A 10 ml portion of genomic DNA (100 mg/ml) purified from U937 and HL-60 cells treated with DMSO control, manumycin 2 mM, NAC 5 mM, or both drugs was incubated with 10 ml of ARP for 1 h at 371C. DNA from cells incubated with hydrogen peroxide and ferrous sulfate (H 2 O 2 180 mM þ Fe 2 þ 20 mM) was used as a positive control. The data for U937 cells are shown in Figure 2 . Manumycin significantly (one-way ANOVA, post hoc between-group comparisons, Tukey's test, Po0.05) increased the number of apurinic sites compared with the control, NAC, and manumycin þ NAC groups. Hydroxyl radicals generating by mixing hydrogen peroxide and ferrous ions clearly increased apurinic sites. NAC blocked the increase in apurinic sites induced by manumycin. Similar results were obtained with HL-60 cells (data not shown).
If manumycin-induced apurinic sites were due to baseexcision repair of ROS-induced DNA damage, then quenching of ROS by NAC would block the increase in apurinic sites after manumycin treatment. Therefore, these results suggested that manumycin increased apurinic sites by causing ROS-mediated DNA damage and that base-excision repair might play a role in the survival of manumycin-treated cells.
Methoxyamine increased manumycin-induced nitric oxide generation and apoptosis
We used simultaneous evaluation of NO generation and apoptosis (dual fluorescent flow cytometry) to help establish the relationship between the two events and the impact of methoxyamine on these events. Eight combinations of manumycin, methoxyamine, and NAC were evaluated for their effect on NO content using the fluorescent NO sensor dye and for apoptosis using annexin V-PE in U937 and HL-60 cells. Representative dual fluorescence scatter plots for U937 cells are shown in Figure 3a In contrast to manumycin, methoxyamine slightly increased the percentage of cells stained by the NO sensor dye only and had no effect on the percentage of cells stained positive by both annexin V and the NO sensor dye in both cell lines. Compared with manumycin alone, the combination of manumycin and methoxyamine further increased the percentage of cells stained by the NO sensor dye only and the percentage of cells stained by both annexin V and the NO sensor dye (one-way ANOVA, post hoc between-group comparisons, Tukey's test, Po0.05).
To determine whether the generation of ROS is essential for manumycin-induced apoptosis and methoxyamine-enhanced manumycin-induced apoptosis, we tested the ability of NAC 5 mM to prevent the increase in NO induced by 6-h treatment with manumycin 2 mM, methoxyamine 5 mM, and both treatments in U937 and HL-60 cells. Three independent experiments were performed. NAC 5 mM completely prevented a manumycin-induced increase in the percentage of cells stained by the NO sensor dye only as well as the percentage of cells stained by both annexin V and the NO sensor dye (Figure 3j and k) . NAC also prevented a methoxyamine-enhanced, manumycin-induced increase in the percentage of cells stained by the NO sensor dye only as well as the percentage of cells stained by both annexin V and the NO sensor dye treated by manumycin plus methoxyamine. NAC blocks the induction of apurinic sites by manumycin A. Apurinic sites on purified DNA after experimental treatments were reacted with ARP. The fluorescence due to ARP bound to DNA was measured. The number of apurinic sites per 100 000 bp of DNA was determined by interpolation of standard curves. The experimental groups were labeled on the horizontal axis. DNA from cells treated with hydrogen peroxide and ferrous sulfate was used as a positive control. The error bars represent the 95% confidence intervals.
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Further evidence of enhancement of manumycininduced apoptosis by methoxyamine
In addition to the evidence of apoptosis provided by annexin V binding, we sought further evidence by tracing the subsequent events in apoptosis, namely cytochrome c release; activation of caspase-9, which follows the interaction of cytosolic cytochrome c and APAF-1; activation of caspase-3, which follows the activation of caspase-9; specific cleavage of PARP, which follows the activation of caspases; and the appearance of apoptotic bodies with sub-G1 DNA contents (a late apoptotic event).
Methoxyamine enhanced manumycin-induced release of cytochrome c from mitochondria into cytosol: Translocation of cytochrome c into cytosol is an important event in apoptotic signaling. Cultured cells were divided into four treatment groups: DMSO control, manumycin 2 mM, methoxyamine 5 mM, or both drugs. After treatment for 6 h, cytochrome c released into the cytosol was extracted with a digitonin buffer. 11 Methoxyamine enhanced the release of cytochrome c by manumycin in U937 and HL-60 cells (Figure 4a ). Immunoblotting with anti-cytochrome c oxidase subunit 4 (COX4) showed that there was no significant contamination of the cytosolic extracts with mitochondrial contents. Purified mitochondrial proteins were included on the gel as positive control for anti-COX4 immunoblotting.
Methoxyamine enhanced manumycin-induced activation of caspase-9: Activation of caspase-9 follows the interaction of cytosolic cytochrome c and APAF-1. Thus, we next investigated the activation of caspase-9. Cultured cells were divided into four treatment groups: DMSO control, manumycin 2 mM, methoxyamine 5 mM, or both drugs for 16 h. The duration of treatments was arbitrarily longer than the duration for the cytochrome c experiments, as activation of caspase-9 is a later apoptotic event. As shown in Figure 4b , the combination of manumycin and methoxyamine caused the activation of caspase-9 (decrease in pro-caspase-9 and increase in specific cleavage-activated caspase-9) in both cell lines.
Methoxyamine enhanced manumycin-induced activation of caspase-3: Activation of caspase-3 follows the activation of caspase-9. Thus, we next investigated the 
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Methoxyamine enhanced manumycin-induced PARP cleavage: Specific cleavage of PARP follows activation of caspases. To further confirm the enhanced induction of apoptosis by manumycin and methoxyamine, specific cleavage of PARP was tested in U937 and HL-60 cells treated with DMSO control, manumycin 2 mM, methoxyamine 5 mM, or both drugs for 16 h. As shown in Figure 4d , the combination caused clear and enhanced cleavage of PARP compared to either drug alone.
Methoxyamine enhanced manumycin-induced generation of apoptotic bodies: As apoptosis progresses into the late stage, apoptotic bodies with partially degraded DNA and DNA cleaved at internucleosomal sites appear. These apoptotic bodies were detected as the sub-G1 fraction on propidium iodide fluorescent flow cytometry analysis. HL-60 and U937 cells were treated for 16 h with control medium, manumycin 2 mM, methoxyamine 5 mM, or both drugs and subsequently stained with propidium iodide for flow cytometry. The cellular Enhancement of manumycin A-induced apoptosis by methoxyamine M She et al DNA content analysis revealed that manumycin plus methoxyamine induced more apoptosis than did either manumycin or methoxyamine alone in both cell lines (Figure 4e) . The average percentages of the sub-G1 cells are plotted in Figure 4f .
Methoxyamine enhanced manumycin-induced inhibition of clonogenicity and survival
To evaluate the impact on clonogenicity of HL-60 and U937 cells, the method of colony formation in soft agar was employed. The reduction of manumycin concentration to 1 mM was necessary; otherwise, the colony counts were too low. The average ability to form colonies in soft agar relative to the control group is plotted in Figure 5a for each treatment group for U937 and HL-60 cells. Methoxyamine enhanced the inhibition of colony formation by manumycin.
To evaluate the impact on cell survival of methoxyamine enhancement of manumycin-induced apoptosis in HL-60 and U937 cells, we evaluated the combination effect of manumycin with methoxyamine in cultures of HL-60 and U937 cells seeded onto 96-well plates overnight. The cells were treated with a range of concentrations of manumycin (0-10 mM) and methoxyamine (0-9 mM) for 48 h. The cell viability in each sample was measured using a standard formazan dye assay (MTT assay). The dose-response curve of manumycin was shifted to the left by methoxyamine (Figure 5b) . Therefore, we concluded that methoxyamine enhanced the cytotoxic effect of manumycin on HL-60 and U937 cells. The median-effect method of Chou and Talalay 12 was used to evaluate for synergism between manumycin and methoxyamine. As shown in Figure 5c , the CI was less than 1 (Po0.05) in both cell lines, which indicated synergism in the combination of manumycin and methoxyamine.
Antioxidants blocked manumycin-plus-methoxyamineinduced apoptosis
If enhanced release of cytochrome c by the combination of manumycin and methoxyamine was mediated by increase in ROS, then quenching of ROS by NAC would be expected to block the release of cytochrome c. We tested the role of ROS in manumycin-plus-methoxyamine-induced cytochrome c release in U937 and HL-60 cells by treating the cells with manumycin and methoxyamine in the presence or absence of NAC. As shown in Figure 6a , NAC completely blocked the release of cytochrome c by the combination in both cell lines.
To further investigate whether NAC could protect leukemia cells from the cytotoxicity of manumycin and methoxyamine, we measured the relative viability of cells (MTT assay) treated for 48 h with control medium, manumycin 2 mM, methoxyamine 5 mM, or both drugs in the presence (black bars) or absence (gray bars) of NAC 5 mM (Figure 6b ). The results of three independent experiments in U937 cells are plotted. Similar data for HL-60 cells are not shown. Concurrent treatment with NAC completely prevented the decrease in viability seen with manumycin treatment. The relatively small decrease in viability seen with methoxyamine treatment was blocked incompletely by NAC. The viability of cells treated with manumycin plus methoxyamine plus NAC was the same as that of cells treated with methoxyamine plus NAC. These results suggested that part of the small effect of methoxyamine on viability was not mediated by ROS and that a big proportion of the large effect of manumycin plus methoxyamine on viability was mediated by ROS. Nevertheless, NAC antagonized the synergistic antineoplastic effect of manumycin and methoxyamine.
In U937 cells, inhibition of nitric oxide synthase with L-NAME (1 mM) (Figure 6c, light gray) or L-NMMA (1 mM) (Figure 6c , dark gray) partially blocked the increase in sub-G1 cell cycle fraction induced by manumycin plus methoxyamine, and so did scavenging hydrogen peroxide with catalase (600 U/ml) (Figure 6c, black) . Therefore, NO was not the only ROS responsible for the enhanced apoptosis in manumycin plus methoxyamine, but peroxides might be involved as well.
Discussion
We found that methoxyamine enhanced the apoptotic effect of manumycin. Our results corroborated and extended the findings of Selleri et al 4 about induction of NO in chronic Enhancement of manumycin A-induced apoptosis by methoxyamine M She et al myeloid leukemia. We found that manumycin induced apoptosis and NO in two acute myeloid leukemia cell lines. Using simultaneous detection of NO and early apoptosis by flow cytometry, a close relationship between NO generation and apoptosis was obvious. The majority of the apoptotic cells had increased NO. More importantly, quenching ROS by NAC blocked manumycin-induced apoptosis. Our data are consistent with inhibition of repair of ROS-mediated DNA damage as the mechanism of interaction between methoxyamine and manumycin. Mitochondria are a rich source of ROS, which are toxic byproducts of aerobic cells and play a significant role in apoptosis. 13, 14 The importance of chemotherapy-induced change in redox status in signaling apoptosis and regulating apoptosis effector mechanisms is emerging as a common pattern. 13 We studied the production of NO in U937 and HL-60 cells treated with manumycin and methoxyamine. Our results provided solid evidence of enhancement of manumycininduced apoptosis by methoxyamine, namely cytochrome c release, activation of caspase-9, activation of caspase-3, specific cleavage of PARP, and increase in the sub-G1 fraction. Our finding that NAC blocked cytochrome c release induced by the combination of manumycin and methoxyamine indicated that NO was in a hierarchical position higher than cytochrome c release in the apoptotic signaling cascade.
Base-excision repair can be a potential therapeutic target to enhance the antineoplastic effect of chemotherapy. 8 Manumycin increased apurinic sites in DNA as measured using ARP, which reacted to the apurinic sites. Manumycin had the means to damage DNA, that is, increase in ROS. Methoxyamine disrupts base-excision repair of DNA by reacting with the apurinic sites and preventing endonuclease cleavage, 7 and methoxyamine increased manumycin-induced apoptosis. No matter whether manumycin-induced DNA damage was intended or unintended, we have a strong case supporting manumycin plus methoxyamine as a rational combination for myeloid leukemia.
As an overall assessment of the antineoplastic effect of methoxyamine plus manumycin, we measured both cell survival and clonogenicity in soft agar. Methoxyamine enhanced manumycin-induced inhibition of clonogenicity and survival. This suggested the overall importance of base-excision repair in the survival of manumycin-treated cells. NAC blocked manumycin-plus-methoxyamine-induced release of cytochrome c and decrease in cell viability. Inhibitors of NO synthase and scavenger of hydrogen peroxide partially block manumycinplus-methoxyamine-induced apoptosis. These pieces of data reaffirmed the importance of NO and other ROS in the signaling of apoptosis after manumycin treatment.
In summary, we evaluated a novel drug combination (manumycin plus methoxyamine) against two leukemia cell lines. ROS may be mechanistically involved in manumycin-and manumycin-plus-methoxyamine-induced apoptosis. Our finding of enhanced apoptosis in this drug combination was consistent with the notion that interference with base-excision repair of ROS-mediated DNA damage after manumycin treatment decreased cell survival. In the search for more efficacious therapy for leukemia, these studies indicate the possibility of other novel combinations of FTIs and DNA repair inhibitors for leukemia therapy in the future.
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